Clinical Trial Update: Adaptive Neoadjuvant Therapy for Esophageal Cancer [NA]

View source ↗

Summary

This clinical trial update indicates an adaptive neoadjuvant therapy study for esophageal cancer is currently enrolling by invitation. It is sponsored by Cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | Conditions: Esophageal Carcinoma, Neoadjuvant Therapy | NA | Status: ENROLLING_BY_INVITATION